Global Clinical Decision Support System Market

Clinical Decision Support System Market Size, Share, Growth Analysis, By Product(Standalone CDSS, Integrated CPOE with CDSS, Integrated E.H.R. with CDSS, Integrated CDSS with CPOE & E.H.R.), By Application(Drug-drug Interactions, Drug Allergy Alerts, Clinical Reminders, Clinical Guidelines), By Deployment Mode(Web-based Systems, Cloud-based Systems, On-premise Systems), By Component(Hardware, Software, Services), By Region - Industry Forecast 2024-2031


Report ID: SQSG45F2024 | Region: Global | Published Date: February, 2024
Pages: 260 | Tables: 121 | Figures: 74

Clinical Decision Support System Market Regional Insights

A large portion of the global market for clinical decision support systems is expected to be dominated by North America due to the region's higher adoption of clinical decision systems by healthcare organisations. In addition, the introduction of new technologies to integrate existing data handling systems, such as EHR and clinical decision systems, are providing patients with predictive scenarios, which are responsible for better patient experience and treatment.

Due to the region's rapidly expanding patient population and growing demand for software assistance in managing this expanding patient population, Asia Pacific has enormous potential for growth of the world's clinical decision support systems. Additionally, it is expected that increased cooperation between healthcare organisations and information technology firms for the development of new systems will accelerate the growth of clinical decision support systems globally in the Asia Pacific region.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Clinical Decision Support System Market size was valued at USD 2.78 billion in 2022 and is poised to grow from USD 3.01 billion in 2023 to USD 5.61 billion by 2031, growing at a CAGR of 8.10% in the forecast period (2024-2031).

The market is indeed not overly highly competitive. The market has been distinguished by the presence of prominent participants as well as other clinical decision support system suppliers. To gain a competitive advantage over one another, these players engage in new product launches, product innovations, acquisitions, and partnerships. 'Cerner Corporation', 'Allscripts Healthcare Solutions, Inc.', 'McKesson Corporation', 'Philips Healthcare', 'GE Healthcare', 'Wolters Kluwer Health', 'Epic Systems Corporation', 'Siemens Healthineers', 'IBM Watson Health', 'Athenahealth, Inc.', 'Carestream Health', 'Clinical Computer Systems, Inc.', 'Meditech', 'NextGen Healthcare', 'Intersystems Corporation', 'Elsevier B.V.', 'Hearst Health', 'Decision Support Systems, Inc.', 'DXC Technology', 'Truven Health Analytics (a part of IBM Watson Health)'

The European Union's health ministers agreed to work together and create an eHealth common area in 2021, allowing for the free flow of electronic health records throughout the continent. The declaration also urges the inclusion of eHealth as a key component of the Europe 2021 strategy. Such policies/initiatives are expected to increase the demand for and uptake of EHR, which will have an impact on the uptake of CDSS in important global markets.

The growth of partnerships between CDSS providers and hospitals has significantly increased during the last few years. The demand is expected to rise even more as a result of government recognition and activities to promote the deployment of CDSS and EHR systems. By lowering the amount of time spent looking up a patient's medical history and records, integration with electronic health records (EHR) increases the effectiveness of clinical care. Additionally, the Health and Medicare Acts of the United States Government have approved CDSS, financially rewarding CDS integration into EHRs (Electronic Health Records). A CDSS was present in approximately 41% of American hospitals with an EHR in 2021, and a cutting-edge CDS was available in 40.2% of American hospitals in 2021. Additionally, businesses collaborate to create and offer software that is updated with the most recent data.

A large portion of the global market for clinical decision support systems is expected to be dominated by North America due to the region's higher adoption of clinical decision systems by healthcare organisations. In addition, the introduction of new technologies to integrate existing data handling systems, such as EHR and clinical decision systems, are providing patients with predictive scenarios, which are responsible for better patient experience and treatment.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Clinical Decision Support System Market

Report ID: SQSG45F2024

$5,300
BUY NOW GET FREE SAMPLE